Skip to main content

Animations

MJFF Publications

691 - 700 of 8587 Results
Title
Year
  • Year
  • 2021
  • 2022
  • 2022
  • 2012
  • 2016
  • 2020
  • 2017
  • 2013
  • 2017
  • 2018
  • Summary Details
    OPEN
    Title: Identification of proteins and cellular pathways targeted by 2-nitroimidazole hypoxic cytotoxins
    Journal Name: Redox Biology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.redox.2021.101905
    Citation Count: 4
  • Summary Details
    RESTRICTED
    Title: Should “on-demand” treatments for Parkinson’s disease OFF episodes be used earlier?
    Journal Name: Clinical Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.prdoa.2022.100161
    Citation Count: 7
  • Summary Details
    RESTRICTED
    Title: PLA2G6-associated neurodegeneration in four different populations-case series and literature review
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.016
    Citation Count: 4
  • Summary Details
    RESTRICTED
    Title: Analysis of Copy Number Variation in Alzheimer’s Disease in a Cohort of Clinically Characterized and Neuropathologically Verified Individuals
    Journal Name: PLoS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0050640
    Citation Count: 53
  • Summary Details
    RESTRICTED
    Title: Activation Mechanism of LRRK2 and Its Cellular Functions in Parkinson’s Disease
    Journal Name: Parkinson's Disease
    Publisher: Hindawi Limited
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1155/2016/7351985
    Citation Count: 24
  • Summary Details
    OPEN
    Title: Improved motion correction for functional MRI using an omnibus regression model
    Journal Name: 2020 IEEE 17th International Symposium on Biomedical Imaging (ISBI)
    Publisher: IEEE
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1109/isbi45749.2020.9098688
    Citation Count: 2
  • Summary Details
    RESTRICTED
    Title: Chaperone-Based Therapies for Disease Modification in Parkinson’s Disease
    Journal Name: Parkinson's Disease
    Publisher: Hindawi Limited
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1155/2017/5015307
    Citation Count: 34
  • Summary Details
    RESTRICTED
    Title: What’s to like about the prion-like hypothesis for the spreading of aggregated α-synuclein in Parkinson disease?
    Journal Name: Prion
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.4161/pri.23806
    Citation Count: 54
  • Summary Details
    RESTRICTED
    Title: The role of microbial amyloid in neurodegeneration
    Journal Name: PLOS Pathogens
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.ppat.1006654
    Citation Count: 272
  • Summary Details
    RESTRICTED
    Title: Novel genetic associations for blood pressure identified via gene-alcohol interaction in up to 570K individuals across multiple ancestries
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc0
    DOI - Digital Object Identifier: 10.1371/journal.pone.0198166
    Citation Count: 83
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.